Drug Addiction, Facts About Addiction, Substance Abuse  |  May 12, 2016

When Purdue Pharma first launched its blockbuster opioid painkilling drug Oxycontin in the mid-1990s – they did so with the claim that the drug provided relief for a full twelve hours.  And the generic alternatives didn’t come close.

Thirty-one billion dollars in profit and an epidemic of opioid painkiller addiction later – it turns out that claim of 12 hour effectiveness was a false claim.

A knowingly


claim, according to a report in the LA Times.

Why does it matter?

Believe it or not, Oxycontin is a close cousin of heroin.  And like heroin, when the drug starts to wear off, the person using it often experiences extreme discomfort including body aches, nausea, painful anxiety and other symptoms of withdrawal.   Relief is provided by taking another dose - and low and behold – the addiction cycle of pain and euphoria has been initiated.

So what did Purdue Pharma know – and what steps did they take?  Here is an excerpt from the LA Times story:

Since the drug was released, over 7 million Americans have struggled with abuse and addiction to Oxycontin.

Close to 200,000 have died.

According to the LA Times, Oxycontin was Purdue Pharma’s solution to a vexing business problem.  The patent on a very profitable painkiller for cancer patients – MS Contin - was about to expire and as a result the company faced an enormous financial problem.

How’d they solve it?

They took an old drug (Oxycodone) and adjusted it’s formulation to create a time-release product with the claim it would provide relief for a full twelve hours.  On that claim – it was indeed a market winner.

A $31 billion market winner.

As we now know – that claim was false.  And the consequences dire.

If you or someone you know is addicted to an opioid painkiller and needs help, consider working with Aware Recovery Care in Connecticut.  Aware Recovery Care is bringing full recovery to its clients at a rate 650% above the national average.

If you would like our help, visit www.awarerecoverycare.com to learn more.

Photo credit: StockMonkeys.com via Foter.com / CC BY